Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate for angiographic luminal loss after endovascular treatment in peripheral artery disease
KCT0004511Phase 4Not yet recruiting
- Sponsor
- Dong-A University Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in arteriosclerosis obliterans, sponsored by Dong-A University Hospital. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
sarpogrelate
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on KCT0004511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004511.